Logistics implications of the UK packaging waste regulations

This paper examines the Producer Responsibility Obligations (Packaging Waste) Regulations introduced by the UK Government in 1997. The impact that these Regulations will have on the levels of freight transport activity associated with the collection and redistribution of packaging waste to recovery/recycling facilities is calculated. Findings indicate that the Regulations will lead to a 14% increase in freight vehicle kilometres attributable to packaging waste. The extent to which greater use of reusable containers could help to reduce packaging waste-related transport activity is also modelled. Details arc given of how businesses are responding to the Regulations and how some companies are adapting their logistics systems to incorporate the recovery and recycling of packaging waste as well as replacing disposal packaging with reusable containers. Interviews and case-study material carried out as part of the research are used to support this discussion.

Identification of a Novel Recycling Sequence in the C-tail of FPR2/ALX Receptor: Association with Cell Protection from Apoptosis

Formyl-peptide receptor type 2 (FPR2; also called ALX because it is the receptor for lipoxin A4) sustains a variety of biological responses relevant to the development and control of inflammation, yet the cellular regulation of this G-protein-coupled receptor remains unexplored. Here we report that, in response to peptide agonist activation, FPR2/ALX undergoes β-arrestin-mediated endocytosis followed by rapid recycling to the plasma membrane. We identify a transplantable recycling sequence that is both necessary and sufficient for efficient receptor recycling. Furthermore, removal of this C-terminal recycling sequence alters the endocytic fate of FPR2/ALX and evokes pro-apoptotic effects in response to agonist activation. This study demonstrates the importance of endocytic recycling in the anti-apoptotic properties of FPR2/ALX and identifies the molecular determinant required for modulation of this process fundamental for the control of inflammation.